Genialis krasID, the first AI/ML biomarker algorithm that can predict patient response and clinical benefit to KRAS ...

(Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, ...

Researchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of ...

These compounds were used to represent: Targeted drugs which block a cancer-causing protein called KRAS G12C. These have been approved for use in lung cancer, but often fail to benefit patients in the ...

Q2 2024 Earnings Call Transcript September 24, 2024 Operator: Good morning, and welcome to the Altamira Therapeutics First ...

Researchers at the Francis Crick Institute, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to ...

Alkermes plc announced today that it will host an investor event for financial analysts and institutional investors on Wednesday, Oct. 9, 2024 starting at 10:00 a.m. EDT in Waltham, Mass. Members of ...

Gig roles are emerging in India's corporate sector, with IT, pharmaceuticals, and energy firms hiring senior executives on ...

Plastic Surgeons of America (PSofA), a new product from Hyperspace Ventures, is set to revolutionize the plastic surgery industry with its cutting-edge platform designed to enhance the way patients ...

These compounds were used to represent: Targeted drugs which block a cancer-causing protein called KRAS G12C. These have been ...

Company to host conference call today at 8.30 a.m. ET Continued progress within core activities in RNA delivery, supported by move into new R&D facilities Publications by independent research groups ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...